Sign In
Home
Viokace - Pancrelipase tablet
Get your patient on
Viokace - Pancrelipase tablet
(Pancrelipase)
oral pill - 39,150-10,440-39,150 unt tab
Check coverage
See the specific documentation and step therapies required.
Check coverage
Prescribing info
PubMed™ news
Viokace - Pancrelipase tablet prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Viokace - Pancrelipase tablet PubMed™ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Viokace - Pancrelipase tablet
,
view all articles on PubMed™
Journal Article • 2026 May
Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic Pancreatitis.
Journal Article • 2026 Mar
Efficacy of pancreatic enzyme replacement therapy (PERT) in the treatment of gastrointestinal symptoms after gastric cancer surgery: study protocol for a multicenter randomized controlled open-label trial.
Journal Article • 2026 Jan
Prescribing Patterns and Perceptions of Pancreatic Enzyme Replacement Therapy among Healthcare Providers: A Prospective United States Healthcare Providers Survey.
Journal Article • 2026 Jan
Exocrine Pancreatic Insufficiency Treated With Pancreatic Replacement Enzyme in a Premature Neonate: A Case Report.
Journal Article • 2025 Nov
Exocrine pancreatic insufficiency in a patient with regionally recurrent cutaneous squamous cell carcinoma undergoing treatment with cemiplimab.
Show the latest PubMed™ articles for Viokace - Pancrelipase tablet
I certify that I'm a U.S. healthcare provider